Ustredni Vojenska Nemocnice Vojenska Fakultni Nemocnice Praha — Clinical Trial Site

15 Registered trials

6 Currently recruiting

Organisation

Ustredni Vojenska Nemocnice Vojenska Fakultni Nemocnice Praha

Location

Prague 6, Czechia

Identifier

ORG-100022766

Address

U Vojenske Nemocnice 1200, 169 02, Czechia

Departments

20304:Ocni klinika
Diabetologické centrum
Interni klinika
Interní klinika 1. LF UK a ÚVN
Interní klinika 1. LF UK a UVN, oddeleni kardiologie
Kardiologické oddělení
Kardiovaskulární centrum a oddělení kardiologie
KARIM 1. LF UK a ÚVN
Komplexni cerebrovaskularni centrum
Neurologické oddělení - Cerebrovaskulární centrum
Oční klinika
Oční klinika 1.LF UK a ÚVN Praha
Ocni klinika UVN
Oddělení kardiologie

Clinical trials at this site (15)

Search interface

Reducing Non-Alcoholic Steatohepatitis Pending

2024-518334-88-00 Metabolic dysfunction-associated steatohepatitis 6
A clinical study to evaluate the effects of RO7795068 in participants with obesity or overweight and type 2 diabetes Recruiting

2025-523106-32-00 Obesity or Overweight and Type 2 Diabetes 5 2026-05-25
Darovasertib before Surgery or Radiation Therapy to Treat Early-stage Eye Cancer (Uveal Melanoma) Recruiting

2025-522387-32-00 Uveal Melanoma 5 2026-04-10
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham… Recruiting

2023-504655-27-00 Primary Indeterminate Lesions or Small Choroidal Melano 5 2024-12-23
Study to Assess the Injection Burden, Safety, Efficacy, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec (ABBV-RGX-314) … Recruiting

2024-512298-28-00 Neovascular age-related macular degeneration 11 2025-12-18
Effects of goal-directed fluid management guided by a non-invasive device on the incidence of postoperative complications in neurosurgery: a… Recruiting

2024-511153-21-00 elective neurosurgery treating unspecified brain condit 6 2025-11-27
Phase IIIb Study of 36-Week Refill Exchanges of Port Delivery System with Ranibizumab in nAMD Recruiting

2024-516924-32-00 Neovascular Age-Related Macular Degeneration (nAMD) 5 2025-10-17
LIBREXIA-AF A Phase 3 Active-controlled Study of Milvexian for Prevention of Cardioembolic Events in Participants with Atrial Fibrillation Ended

2022-501419-15-00 Atrial Fibrillation 5 2023-08-23
A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended

2022-501176-26-00 Acute Ischemic Stroke and High-Risk Transient Ischemic 5 2023-08-04
A Placebo-Controlled Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With Atherosclerotic Cardiovascular Disease … Ended

2023-507795-51-00 atherosclerotic heart and blood vessel disease (the nar 5 2022-05-17
A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 Acute Coronary Syndrome 5 2023-11-21
A Phase 2 Study of the Effects of Ponsegromab on Health-Related Quality of Life and Safety in Patients With Heart Failure (GARDEN-TIMI 74) Ended

2023-509747-27-00 Heart failure 4 2023-05-18
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended

2023-503793-20-00 Prevention of ischemic stroke in patients post acute no 5 2023-01-18
Zibotentan and Dapagliflozin combination, Evaluated in Liver cirrhosis (ZEAL study) Ended

2023-505405-17-00 Liver cirrhosis with features of portal hypertension. 4 2022-10-07
A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) Ended

2022-500881-80-00 Chronic Heart Failure With Reduced Ejection Fraction 5 2021-10-29